Torrent Pharmaceuticals has acquired an additional 37,82,566 equity shares of J.B. Chemicals & Pharmaceuticals Limited, representing 2.36% of its equity share capital. This acquisition increases Torrent Pharma’s total holding in J.B. Chemicals to 7,82,65,402 equity shares, representing 48.75% of the equity share capital on a fully diluted basis. The shares were acquired from certain employees of J.B. Chemicals as per a share purchase agreement.
Increased Stake in JB Chemicals
Torrent Pharmaceuticals has announced the acquisition of additional equity shares in J.B. Chemicals & Pharmaceuticals Limited (“JB Chemicals”). The transaction, completed on January 23, 2026, further consolidates Torrent Pharma’s position in JB Chemicals.
Details of the Acquisition
The company acquired 37,82,566 equity shares of JB Chemicals, representing approximately 2.36% of the equity share capital on a fully diluted basis. These shares were purchased from certain employees of JB Chemicals, in accordance with the share purchase agreement dated July 3, 2025.
Revised Shareholding
Following this acquisition, Torrent Pharmaceuticals now holds an aggregate of 7,82,65,402 equity shares in JB Chemicals. This translates to approximately 48.75% of the total equity share capital of JB Chemicals on a fully diluted basis.
Source: BSE
